Uncategorized Archives - Page 22 of 1028

WednesdayJul 01, 2026 11:15 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Advances Santa Fe, Walker Lane amid Tightening Gold Supply Dynamics

Disseminated on behalf of  Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Top gold-producing countries are showing strain of widespread government, cost and environmental pressures. These pressures strengthen the case for secure, transparent and infrastructure-supported gold development in the United States. Existing mine infrastructure, historical production, oxide material and location in a leading U.S. gold state may give Lahontan’s Santa Fe project a different development profile. Global gold supply is entering a more complicated era, shaped not only by geology and discovery rates but also by government policy, rising operating costs, safety enforcement, environmental oversight and growing…

WednesdayJul 01, 2026 10:40 am

Why VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Pay Serious Attention to Antibody Therapeutics Sector Deals

Deal activity remains strong in antibody-drug conjugates (ADCs) and T-cell engager (TCE) therapeutics, with pharmaceutical companies continuing to commit substantial capital to preclinical and early-stage innovation. The Jazz Pharmaceuticals–AbCellera collaboration illustrates how differentiated antibody technologies can command significant financial commitments before entering clinical development. VERAXA Biotech AG is positioning its technology platform across both ADCs and T-cell engagers, two therapeutic modalities that continue to attract strategic partnerships and acquisitions. Platform technologies and individual drug candidates both represent potential avenues for future partnering, licensing, and collaboration agreements. Recent transactions across the sector demonstrate that pharmaceutical companies are actively seeking access to…

WednesdayJul 01, 2026 10:30 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Delivers First Edge AI Intoxication Detection Kiosk Prototypes

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio kiosks use artificial intelligence and voice analysis to detect potential intoxication and fatigue in workplace environments. The company is targeting industries such as mining, aviation, construction, transportation, and law enforcement, where safety-sensitive operations require large-scale screening. MindBio’s AI models have been trained on more than 50 million data points and analyze over 140 acoustic markers associated with impairment. Prototype kiosks are entering testing, validation, and data-analysis phases, before broader commercial deployment. The company is positioning this important new technology as a faster and…

WednesdayJul 01, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Showcases Unique MS Drug Candidate, Growth Strategy During Executive Podcast

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma executive co-chairman and co-founder Anthony Durkacz appeared as a guest on the BioMedWire Podcast. Durkacz outlined the company’s strategy for advancing Lucid-MS, the company’s lead drug candidate for multiple sclerosis. The Quantum BioPharma exec also provided an update on unbuzzd, the company’s innovative, clinically validated alcohol metabolism accelerator designed to help sober people up faster. Executive thought leadership has become an increasingly important component of corporate communications, particularly in highly specialized industries such as biotechnology. Through podcasts, interviews and other educational forums,…

WednesdayJul 01, 2026 9:00 am

Rare Earths in 2026: Structural Deficits Open Ground for Junior Developers Like Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF)

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. The global rare earth elements market is projected to grow from roughly $14 billion in 2025 to more than $41 billion by 2034, driven by accelerating demand from EV traction motors, wind turbines, consumer electronics, and defense applications China continues to dominate rare earth mining and processing capacity, leaving Western manufacturers exposed to persistent supply concentration risk as governments push to build alternative supply chains Canamera Energy Metals raised approximately $10.2 million over four months ending March 2026 and is advancing active exploration…

TuesdayJun 30, 2026 12:00 pm

American Fusion(TM) Inc. (AMFN) Files Additional Texatron(TM) Patent Application as Development Advances Toward Testing Milestones

American Fusion(TM) continues development of its 5MW pre-production Texatron(TM) Fusion Engine(TM) and is progressing toward planned testing activities in Texas. Regulatory engagement with the Texas Department of State Health Services remains underway as the company advances certification and licensing requirements. The company is expanding its intellectual property strategy to protect future innovations involving reactor architecture, plasma systems, and commercial deployment methods. Through its wholly owned subsidiary Kepler Fusion Technologies, the company is developing multiple Texatron(TM) system designs aimed at modular energy deployment. The company’s broader commercialization strategy focuses on scalable fusion systems for industrial, commercial, and grid-related energy applications. American…

TuesdayJun 30, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Ramps Up Operations Team as Montauban Project Advances Toward Production

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, recently appointed Pierre-Marc Gagnon, P.Eng., as the Operations Director for the Montauban Project Mr. Gagnon brings operational and technical expertise in drilling, field coordination, technical planning, mine operations and development, and more The appointment comes as continues to advance construction and operational readiness activities at its Montauban Project In his role, Mr. Gagnon will support site execution, operational readiness, contractor coordination, technical planning, and continued development at the…

TuesdayJun 30, 2026 10:30 am

HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring toward a more comprehensive understanding of cardiovascular health. HeartBeam’s proprietary HeartBeam System reflects the company’s mission to make cardiac monitoring accessible beyond the walls of a medical facility. The synthesized 12-lead ECG view provided by the system can help clinicians evaluate rhythm abnormalities and identify rhythm changes that may warrant additional investigation. Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions outside of…

TuesdayJun 30, 2026 9:45 am

From Hospitality to Pharma: TechForce Robotics Expanding Its Robotics-as-a-Service Platform into Laboratory Automation

TechForce Robotics has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking the company's first operational entry into pharmaceutical and laboratory automation. The deployment fulfills Phase 1 objectives under a joint development agreement designed to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows. A new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise that could support the expansion of high-precision AI-driven applications. Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries from manufacturing to hospitality: how to…

TuesdayJun 30, 2026 9:00 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Onco-Innovations is advancing a new class of DNA Damage Response ("DDR") therapies through the development of Polynucleotide Kinase Phosphatase ("PNKP") inhibitors designed to disrupt cancer cells' ability to repair DNA damage. The company recently achieved a key manufacturing milestone with the successful advancement toward kilogram-scale production of the active pharmaceutical ingredient in its lead drug candidate, ONC010. A newly signed Letter of Intent with Nanosoft Polymers is expected to support polymer development, drug delivery optimization and formulation work for the ONC010 program. Cancers frequently exhibit defective repair…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Uncategorized